About FDA

FDA-TRACK NCTR Dashboard

Sign up to receive FDA-TRACK updates

Contents:

 NCTR Strategic Plan -

Note: Information is as of June 30, 2018.  The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updating preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time.

STRATEGIC GOAL 1: Advance scientific approaches and tools required to support public health

Objective 1.1 - Integrated product assessment 

Division of Biochemical Toxicology

I. Bisphenol A (BPA) Data Gap Analysis

Office of Scientific Coordination

II. Physiologically-Based Pharmacokinetic (PBPK) Modeling of Nanomedicine

Objective 1.2 - Advance regulatory science through the development of new tools and approaches

Division of Bioinformatics and Statistics

I. Sequencing Quality Control Phase II (SEQC2)

Objective 1.3 - Approaches for promoting individualized health and identifying susceptible subpopulations

Measures are under development and will be available once finalized.

Go back to the top


STRATEGIC GOAL 2:
Promote global interactions in regulatory science

Objective 2.1 - Promote global scientific interactions

I. Outreach Measures

A. Maintain / enhance the collaborations (e.g., FDA Product Centers, government agencies, and industry) and increase outreach to advance communication of scientific knowledge.

  1. Number of manuscripts submitted to peer-reviewed journals in the quarter
  2. Total number of Eloqua Subscriptions (Research Highlights + Quarter Page) at the end of the quarter

II. Research Publication Measures

A. Increase the submission of manuscripts accepted for publication in scientific journals.

  1. Percentage of manuscripts submitted to scientific journals in the last 12 months which were accepted for publication in the quarter

Go back to the top


STRATEGIC GOAL 3:
Improve administrative management and develop new communication materials and methods to support HHS/FDA science goals

Objective 3.1 - Implement business processes that ensure program integrity and develop best practices to recruit and retain a talented workforce

Measures are under development and will be available once finalized.

Objective 3.2 - Develop communication strategies that help explain how regulatory science research information can lead to public and personalized health gains

Measures are under development and will be available once finalized.

 

Go back to the top

Subscribe

Sign up to receive FDA-TRACK updates

Page Last Updated: 08/14/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English